IRVINE,
Calif., Jan. 24, 2023 /PRNewswire/ --
Edwards Lifesciences (NYSE: EW)
plans to announce its operating results for the quarter ended
December 31, 2022 after the market
closes on Tuesday, January 31, 2023,
and will host a conference call at 5:00
p.m. ET that day to discuss those
results.
To participate in the conference call, dial (877) 704-2848 or
(201) 389-0893. The call will also be available live and archived
on the "Investor Relations" section of the Edwards website at
ir.edwards.com.
About Edwards Lifesciences
Edwards Lifesciences, is
the global leader of patient-focused innovations for structural
heart disease and critical care monitoring. We are driven by
a passion for patients, dedicated to improving and enhancing lives
through partnerships with clinicians and stakeholders across the
global healthcare landscape. For more information, visit
Edwards.com and follow us on Facebook, Instagram, LinkedIn,
Twitter and YouTube.
Edwards, Edwards Lifesciences, and the stylized E logo are
trademarks of Edwards Lifesciences Corporation. All other
trademarks are the property of their respective owners.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/edwards-lifesciences-to-host-earnings-conference-call-on-january-31-2023-301728906.html
SOURCE Edwards Lifesciences Corporation